5HT3E Antibody (Center) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | A5X5Y0 |
---|---|
Other Accession | NP_872395.2 |
Clone Names | 91208215 |
Gene ID | 285242 |
---|---|
Other Names | 5-hydroxytryptamine receptor 3E, 5-HT3-E, 5-HT3E, Serotonin receptor 3E, HTR3E |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | HTR3E (HGNC:24005) |
---|---|
Function | Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation- selective channel complexes, which when activated cause fast, depolarizing responses in neurons. |
Cellular Location | Postsynaptic cell membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein. Note=Presumably retained within the endoplasmic reticulum unless complexed with HTR3A. |
Tissue Location | Expressed in adult colon and intestine. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The product of this gene belongs to the ligand-gated ionchannel receptor superfamily. HTR3E encodes a subunit E of thetype 3 receptor for 5-hydroxytryptamine (serotonin), a biogenichormone that functions as a neurotransmitter, a hormone, and amitogen. This receptor causes fast, depolarizing responses inneurons after activation. Genes encoding subunits C, D and E form acluster on chromosome 3. An alternative splice variant has beendescribed but its full length sequence has not been determined.
References
Walstab, J., et al. J. Biol. Chem. 285(35):26956-26965(2010)Hammer, C., et al. Pharmacogenomics 11(7):943-950(2010)Lennertz, L., et al. Eur Neuropsychopharmacol 20(6):414-420(2010)Goecke, T.W., et al. Acta Obstet Gynecol Scand 89(1):7-14(2010)Schuhmacher, A., et al. Pharmacogenet. Genomics 19(11):843-851(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.